CASI Pharmaceuticals, Inc (DE)
CASIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000895051
CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.
Holders of 5% or more of CASI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CASI Pharmaceuticals, Inc (DE), largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of CASI Pharmaceuticals, Inc (DE) on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on CASI Pharmaceuticals, Inc (DE), newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 20, 202411:40 AM ET | Sparkle Byte Ltd | 13D/AOld format | – | – | – | SEC |
| Feb 21, 2023 | Ho Chi Sing | 13D/AOld format | – | – | – | SEC |
| Feb 9, 202310:48 AM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 1, 202310:39 AM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Jun 21, 2022 | He Wei-Wu | 13D/AOld format | – | – | – | SEC |
| Feb 14, 20221:21 PM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Consonance Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Nov 23, 2021 | He Wei-Wu | 13D/AOld format | – | – | – | SEC |
| Apr 30, 20214:11 PM ET | Spectrum Pharmaceuticals Inc | 13D/AOld format | – | – | – | SEC |
| Feb 17, 2021 | Consonance Capital Management LP | 13GOld format | – | – | – | SEC |
| Feb 16, 2021 | Consonance Capital Management LP | 13GOld format | – | New | – | SEC |
| Feb 12, 20213:01 PM ET | Federated Hermes, Inc. | 13GOld format | – | New | – | SEC |
| Feb 3, 2021 | He Wei-Wu | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CASI Pharmaceuticals, Inc (DE) shares.
No Form 144 notices for CASI Pharmaceuticals, Inc (DE) are on file.